Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210028128 210013827 0.81 null Curative (C) 2017-03-05 2017-07-14 BR14 TRIAL null null 210030882 OFATUMUMAB
210028129 210013829 1.63 10.8 Palliative (P) 2016-10-10 2017-01-20 PNET 4 HIT-SIOP Maintenance 02 N 210030903 CLL210 TRIAL
210028130 210022634 1.7 103.4 null 2019-01-14 2019-02-13 CARFILZOMIB N N 210030950 OBINUTUZUMAB
210028131 210013832 1.7 14.9 Disease modification (D) 2016-04-06 2016-04-08 CNS Medbl Std Risk Maint Cisplatin 02 N 210031032 CVP
210028132 210013833 1.6 97.5 Curative (C) 2017-04-04 2017-04-11 Lenalidomide Cycle 26 onwards (PAS) N N 210031092 CVD
210028133 210013834 null 70.5 null 2016-08-08 2016-12-14 BEAM null null 210031093 FLUOROURACIL
210028134 210022638 0 46.3 Disease modification (D) 2018-07-18 2018-07-18 Cytarabine intrathecal N null 210031157 CYTARABINE INTRATHECAL
210028135 210013838 1.74 68 Curative (C) 2018-11-21 2018-11-28 FLAG N null 210031192 CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE
210028136 210013840 null 19.3 null 2016-10-13 2017-03-30 Cytarabine intrathecal N N 210031205 OBINUTUZUMAB
210028137 210013843 1.83 46 null 2017-05-26 2018-04-23 Cyclophosphamide High Dose Y N 210031222 MYELOMA XI TRIAL
210028138 210031578 1.73 null Adjuvant (A) 2016-05-11 2016-05-11 CARBO + ETOPOSIDE + VINCRISTINE 02 N 210031222 BEAM
210028139 210036931 1.87 0 Curative (C) 2018-04-24 2018-04-28 CLARITY Trial N N 210031422 IMMUNOGLOBULIN
210028140 210022642 1.73 13.4 Curative (C) 2015-08-28 2015-08-31 CYTARABINE + ETOPOSIDE + METHOTREXATE N N 210031422 CISPLATIN + ETOPOSIDE + IFOSFAMIDE
210028141 210013846 1.7 62.9 Adjuvant (A) null 2019-09-14 CARBO + ETOPOSIDE + VINCRISTINE N N 210031442 CARFILZOMIB
210028142 210013847 1.64 21.3 Curative (C) null 2015-12-16 Irinotecan + Temozolomide N N 210031497 BEAM
210028143 210013848 null 79.5 Adjuvant (A) 2015-04-13 2015-04-18 DA 3 + 10 null N 210031558 OXALIPLATIN + MDG
210028144 210022645 1.82 83.4 Palliative (P) 2016-04-08 2018-03-25 BEAM N N 210031596 IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE
210028145 210022645 null null Adjuvant (A) 2016-12-13 2016-12-13 Cytarabine Intrathecal (any age) 02 N 210031596 MARALL TRIAL
210028146 210013851 1.75 66.6 Curative (C) 2018-02-15 2018-03-07 Bortezomib (weekly) 02 N 210031639 DOCETAXEL
210028147 210013853 null 52.3 Disease modification (D) 2016-02-10 2016-02-10 Docetaxel 75mg/m2 (21 day) N null 210031768 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
210028148 210013856 0 58.4 Curative (C) 2015-06-15 2015-06-17 Docetaxel 75mg/m2 (21 day) N N 210031789 CYCLO + FLUDARABINE + RITUXIMAB
210028149 210013857 null null Curative (C) 2018-04-11 2018-04-18 Cytarabine intrathecal null N 210031817 DAUNORUBICIN + VNCRISTINE
210028150 210013859 1.8 26 Disease modification (D) 2017-06-20 2017-10-15 Cytarabine Intrathecal (any age) N N 210031869 CYTARABINE
210028151 210013860 1.7 82.2 Adjuvant (A) 2017-12-11 2017-12-11 PACLITAXEL N N 210031901 ALL
210028152 210022651 1.8 64 Curative (C) 2017-03-24 2017-03-24 FCR IV - Cycle 2 onwards N N 210032089 OFATUMUMAB
210028153 210022652 1.74 74.6 Disease modification (D) 2017-03-13 2017-03-13 Intensification 1 2 3(ALL) (Mtx) null N 210032099 TRASTUZUMAB
210028154 210013863 0 52.3 Disease modification (D) null 2018-02-23 AML17 TRIAL N N 210032185 ALL MAINTENANCE
210028155 210022653 1.61 59 Palliative (P) 2015-05-31 2015-06-01 NHL 2003 Gp B COPADM 1 & 2 02 N 210032185 PILOT TRIAL
210028156 210013867 1.76 88.7 Curative (C) 2017-03-25 2017-03-29 LENALIDOMIDE 2 Y 210032363 CYTARABINE HD + METHOTREXATE HD
210028157 210013869 null 66.7 Curative (C) 2017-11-14 2018-11-02 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE null N 210032409 NILOTINIB
210028158 210022655 1.77 50.1 Curative (C) 2017-01-15 2017-01-16 Alemtuzumab + Cyclophos TBI Allo N N 210032441 UKALL2003
210028159 210022656 1.73 82.3 Curative (C) 2016-12-10 2019-01-27 Nilotinib null N 210032604 RUXOLITINIB
210028160 210013873 null 62.9 Curative (C) null 2017-07-27 FCR IV - Cycle 2 onwards N N 210032637 BEAM
210028161 210013875 1.65 100 Disease modification (D) 2016-07-10 2016-07-16 BEAM Y N 210032710 OFATUMUMAB
210028162 210013876 null 70.4 Curative (C) 2018-09-24 2018-10-22 Fludarabine oral N N 210032730 CAPECITABINE + OXALIPLATIN
210028163 210013877 null 69 Curative (C) null 2018-01-19 PNET 4 HIT-SIOP Maintenance 99 null 210032994 ALEMTUZUMAB + ETOPOSIDE
210028164 210013878 1.54 53 Curative (C) 2017-10-07 2017-10-12 Irinotecan + Temozolomide N null 210033021 CYTARABINE HIGH DOSE
210028165 210028217 1.66 39.1 Palliative (P) 2017-02-27 2017-02-27 CISPLATIN + ETOPOSIDE Y N 210033021 CYCLO + FLUDARABINE + RITUXIMAB
210028166 210013880 1.62 61.8 Palliative (P) 2017-01-17 2017-07-17 ALL UKALL2003 C: Ph VII Maintenance N N 210033199 FLUDARABINE + RITUXIMAB
210028167 210013880 null null Curative (C) 2015-09-06 2016-02-14 TELOVAC TRIAL Y N 210033199 DAUNORUBICIN
210028168 210013887 1.58 64.8 Disease modification (D) 2017-10-16 2017-10-26 FCR IV - Cycle 2 onwards N N 210033602 CYCLOPHOSPHAMIDE + CYTARABINE
210028169 210013890 1.73 83.7 Curative (C) 2019-07-27 2019-08-10 CLARITY Trial N N 210033677 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE
210028170 210013895 null null Palliative (P) 2012-11-21 2013-08-13 Cyclophos + Dex + Lenalidomide 02 N 210033710 NILOTINIB
210028171 210013895 1.72 78 Curative (C) 2017-11-28 2017-11-28 Cytarabine HD + Methotrexate HD N N 210033710 DHAP
210028172 210013896 1.64 19.4 Curative (C) 2017-02-28 2017-06-02 ICE-R (Cycle 1) 2 N 210033781 CYCLO + FLUDARABINE + RITUXIMAB
210028173 210013898 0 65.3 Palliative (P) 2018-12-06 2018-12-19 Nilotinib N N 210033837 HYDROXYCARBAMIDE
210028174 210013902 1.81 null Not known (9) 2018-02-28 2018-05-02 BR14 TRIAL 02 N 210033864 HYDROXYCARBAMIDE
210028175 210013905 1.75 null Curative (C) 2017-05-20 2017-08-05 DACTINOMYCIN + CYCLO + VINCRISTINE 01 N 210033869 CYCLO + FLUDARABINE + RITUXIMAB
210028176 210013907 1.74 66.599 Curative (C) 2014-05-25 2014-05-30 LEAM 02 N 210034063 DARATUMUMAB
210028177 210022675 null null Disease modification (D) 2014-07-10 2014-07-10 BR14 TRIAL 02 Y 210034085 CVP